"l 4" Pill Images
The following drug pill images match your search criteria.
1345
Amlodipine Besylate and Telmisartan
- Strength
- 10 mg / 40 mg
- Imprint
- 1345
- Color
- Gray & White
- Shape
- Capsule/Oblong

P 174
Amlodipine Besylate, Hydrochlorothiazide and Valsartan
- Strength
- 10 mg / 12.5 mg / 160 mg
- Imprint
- P 174
- Color
- Brown
- Shape
- Oval
DANTRIUM 100mg 0149 0033
Dantrolene Sodium
- Strength
- 100 mg
- Imprint
- DANTRIUM 100mg 0149 0033
- Color
- Brown & Orange
- Shape
- Capsule/Oblong

A/P 12.5/45
Alogliptin Benzoate and Pioglitazone Hydrochloride
- Strength
- 12.5 mg / 45 mg
- Imprint
- A/P 12.5/45
- Color
- Red
- Shape
- Round
Featured

Gemtesa
Gemtesa (vibegron) is used to treat overactive bladder symptoms (OAB) in adults or men taking ...
Reviews & ratings

1 / 2
Loading
IG 486
Bupropion Hydrochloride Extended-Release (SR)
- Strength
- 200 mg
- Imprint
- IG 486
- Color
- Pink
- Shape
- Round

314
Mebolic
- Strength
- Multiple Vitamins with Folic Acid and Ubiquinone
- Imprint
- 314
- Color
- Tan
- Shape
- Oval

U4 12
Acetaminophen and Hydrocodone Bitartrate
- Strength
- 325 mg / 10 mg
- Imprint
- U4 12
- Color
- Yellow
- Shape
- Capsule/Oblong

G 410
Propafenone Hydrochloride Extended-Release
- Strength
- 425 mg
- Imprint
- G 410
- Color
- White
- Shape
- Capsule/Oblong

CP 341
Methylphenidate Hydrochloride Extended-Release
- Strength
- 54 mg
- Imprint
- CP 341
- Color
- Red
- Shape
- Capsule/Oblong

41 6
Candesartan Cilexetil and Hydrochlorothiazide
- Strength
- 32 mg / 25 mg
- Imprint
- 41 6
- Color
- White
- Shape
- Oval

I 47
Lamivudine, Nevirapine and Zidovudine
- Strength
- lamivudine 150 mg / nevirapine 200 mg / zidovudine 300 mg
- Imprint
- I 47
- Color
- White
- Shape
- Capsule/Oblong

ER 401
Pramipexole Dihydrochloride Extended-Release
- Strength
- 0. 375 mg
- Imprint
- ER 401
- Color
- White
- Shape
- Round

AN 414
Levomilnacipran Extended-Release
- Strength
- 40 mg
- Imprint
- AN 414
- Color
- Yellow
- Shape
- Capsule/Oblong
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.